Study On The Risk of Mucositis Among The Head And Neck Cancer Patients Receiving Radiation Therapy In 3dcrt/Imrt And Chemotherapy By Cisplatin + 5-Fluorouracil Due To Protein Deficiency

International Journal of Pharmacy and Biomedical Engineering

© 2019 by SSRG - IJPBE Journal

Volume 6 Issue 3

Year of Publication : 2019

Authors : Dr. K.Velavan, M.D., RT., G.Saravanan, M.SC, PGDCR., Robin N Rajan, Pharm D, Akshaya Sreenivasan, Pharm.D, Bitson Augustine, Pharm.D., Jibin Iacob chacko, Pharm D

10.14445/23942576/IJPBE-V6I3P103

How to Cite?

Dr. K.Velavan, M.D., RT., G.Saravanan, M.SC, PGDCR., Robin N Rajan, Pharm D, Akshaya Sreenivasan, Pharm.D, Bitson Augustine, Pharm.D., Jibin Iacob chacko, Pharm D, "Study On The Risk of Mucositis Among The Head And Neck Cancer Patients Receiving Radiation Therapy In 3dcrt/Imrt And Chemotherapy By Cisplatin + 5-Fluorouracil Due To Protein Deficiency," SSRG International Journal of Pharmacy and Biomedical Engineering, vol. 6,  no. 3, pp. 12-17, 2019. Crossref, https://doi.org/10.14445/23942576/IJPBE-V6I3P103

Abstract:

This study aims to determine the severity of mucositis inpatient receiving radiotherapy with chemotherapy in head and neck cancer patients. 29 numbers of head and neck cancer patients enrolled in the study and assigned to treat with radiation therapy and chemotherapy. To analyze the severity of mucositis inpatient on concurrent chemoradiation therapy and to observe the other causes of mucositis including lack of protein in diet the subjects were monitored the severity of Mucositis due to lack of protein in the diet. As a result, good nutrition improves the symptoms of mucositis and reduces the severity of treatment, and also the protein level maintained within ranges seems the severity of mucositis can be reduced.
The consequences of mucositis which include, dysphagia, and weight loss were also reported.

Keywords:

Mucositis, IMRT, 3D-CRT, Cisplatin, 5- fluorouracil, Head and neck cancer

References:

[1] Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. “Epidemiology and risk factors for head and neck cancer” CA Cancer J Clin. 2018; 68(6):394. Epub 2018 Sep 12.
[2] Chiara F, Antonino B, Elena M, Desirée B, Elisa P et al. “Effects of 5-Fluorouracil on Morphology, Cell Cycle, Proliferation, Apoptosis, Autophagy and ROS Production in Endothelial Cells and Cardiomyocytes”. The public library of Science. February 2015.
[3] D. Hopanci Bicakli, et al., “The Effects of Compliance with Nutritional Counselling on Body Composition Parameters in Head and Neck Cancer Patients under Radiotherapy”. Journal of Nutrition and Metabolism. January 2017.
[4] David E. G, Timothy A. C. “Recent Advances in Radiation Therapy”. American Family Physician. December 2008; 1255-1261.
[5] Duffy SA, Ronis DL, McLean S, et al. “Pretreatment health behaviors predict survival among patients with head and neck squamous cell carcinoma”. Journal of Clinical Oncology. 2009; 1969–1975.
[6] Jill J. Radiation Therapy. Journal of the American Medical Association.December 2013; 2691.
[7] Lambrecht M, Nevens D, Nuyts S. “Intensity-modulated radiotherapy versus parotid-sparing 3D conformal radiotherapy”. Effect on outcome and toxicity in locally advanced head and neck cancer. Strahlenther Onkol. March 2013; 223–229.
[8] Logemann JA, Rademaker AW, Pauloski BR, Lazarus CL, Mittal BB, Brockstein B, et al. “Site of disease and treatment protocol as correlates of swallowing function in patients with head and neck cancer treated with chemoradiation”. Head Neck. 2006; 64–73.
[9] Montserrat VL, M.P.H.Gerry O.May H. Stephen. “Oral mucositis in patients undergoing radiation treatment for head and neck carcinoma”. Wiley online library. December 2005.
[10] National Cancer Institute, ʻʻHead and Neck Cancers” March 29, 2017. Retrieved 17 September 2017.
[11] Rademaker AW, Vonesh EF, Logemann JA, Pauloski BR, Liu D, Lazarus CL, et al. “Eating ability in head and neck cancer patients after treatment with chemoradiation: a 12- month follow-up study accounting for dropout”. Head Neck. 2003; 1034–1041.
[12] Rosenthal DI, Lewin JS, Eisbruch A. “Prevention and treatment of dysphagia and aspiration after chemoradiation for head and neck cancer”. Journal of Clinical Oncology. July 2006; 2636–2643.
[13] Simon K, David F H. “The patterns of care study, A nationwide evaluation of the practice of radiation therapy in cancer management”. International Journal of Radiation Oncology. November to December 1976; 1231-1236.
[14] Vicki K, Lidia S, Kavitha R, Karen W, Sumanta P et al., “Head and Neck Cancer – Statistics”. American Society of Clinical Oncology (ASCO). 2019.
[15] Vicki K, Lidia S, Kavitha R, Karen W, Sumanta P, et al., “Head and Neck Cancer – types of treatment”. American Society of Clinical Oncology (ASCO). 2018.
[16] Praveen Jacob Ninan, Dharam Prasath and Mary James, "Toxicity and Tolerability of Paclitaxel and Carboplatin Regime in Patients with Epithelial Ovarian Cancer at a Tertiary Care Hospital" SSRG International Journal of Medical Science 5.1 (2018): 5-9.